Picture of Iconovo AB logo

ICO Iconovo AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-1.17%
3m-30.26%
6m-42.25%
1yr-81.37%
Volume Change (%)
10d/3m+16.55%
Price vs... (%)
52w High-80.25%
50d MA-3.94%
200d MA-35.92%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-38.65%
Return on Equity-45.26%
Operating Margin-646.75%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Iconovo AB EPS forecast chart

Profile Summary

Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    July 24th, 2013
    Public Since
    April 6th, 2018
    No. of Employees
    32
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    se flag iconOMX Nordic Exchange Stockholm
    Shares in Issue
    11,755,875

    ICO Share Price Performance

    Upcoming Events for ICO

    Q1 2024 Iconovo AB Earnings Release

    Iconovo AB Annual Shareholders Meeting

    Iconovo AB Annual Shareholders Meeting

    Q2 2024 Iconovo AB Earnings Release

    Similar to ICO

    Picture of Acarix AB logo

    Acarix AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Aegirbio AB logo

    Aegirbio AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Arcoma AB logo

    Arcoma AB

    se flag iconOMX Nordic Exchange Stockholm

    FAQ